| Type |
Capsule-based, re-fillable,
re-usable, passive dry-powder inhaler, intended for most inhalation
drugs. |
| Capacity |
Variable. 14 capsules with
standard capsule container, up to 20 with large-capacity container. |
| Construction |
Only 6 plastic components. |
| Performance |
Emitted dose in excess of
80% (drug assay). Fine particle fraction formulation dependent, 30-70%
of emitted dose. |
| Airflow
rate |
Usable at low airflow rates,
from as low as 20 litres per minute. Nominal rate 35 litres per minute. |
| Durability |
Target use is 6 months.
Tested to the equivalent of twice-daily use for 26 months. |
| Target
patient population |
Children, adults and elderly
patients. |
| Status of development |
CE Mark file ready. Launched. |
| Cost |
Inexpensive due to simple, durable construction. |
| Patents |
Two patents filed world-wide, granted
in every single major market. |
